Cargando…
The neutrophil–lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003–2016
BACKGROUND: Evidence regarding the neutrophil–lymphocyte ratio (NLR) and mortality risk in diabetes patients is scarce. This study investigated the relationship of the NLR with all-cause and cardiovascular mortality risk in diabetes patients. METHODS: Diabetes patients (n = 3251) from seven National...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541705/ https://www.ncbi.nlm.nih.gov/pubmed/37775767 http://dx.doi.org/10.1186/s12933-023-01998-y |
_version_ | 1785113954213691392 |
---|---|
author | Dong, Gaiying Gan, Man Xu, Shilin Xie, Yanlin Zhou, Ming Wu, Liangliang |
author_facet | Dong, Gaiying Gan, Man Xu, Shilin Xie, Yanlin Zhou, Ming Wu, Liangliang |
author_sort | Dong, Gaiying |
collection | PubMed |
description | BACKGROUND: Evidence regarding the neutrophil–lymphocyte ratio (NLR) and mortality risk in diabetes patients is scarce. This study investigated the relationship of the NLR with all-cause and cardiovascular mortality risk in diabetes patients. METHODS: Diabetes patients (n = 3251) from seven National Health and Nutrition Examination Survey (NHANES) cycles (2003–2016) were included in this study. The cause of death and mortality status of the participants were obtained from National Death Index records. Restricted cubic spline (RCS) was used to visualize the association of the NLR with mortality risk. The maximally selected rank statistics method (MSRSM) was used to determine the optimal NLR cutoff value corresponding to the most significant association with survival outcomes. Weighted multivariable Cox regression models and subgroup analyses were adopted to assess the association of the NLR with all-cause and cardiovascular mortality. Time-dependent receiver operating characteristic curve (ROC) analysis was conducted to evaluate the accuracy of the NLR in predicting survival outcomes. RESULTS: During a median follow-up of 91 months (interquartile range, 55–131 months), 896 (27.5%) of the 3251 diabetes patients died, including 261 (8.0%) with cardiovascular deaths and 635 (19.5%) with noncardiovascular deaths. The RCS regression analysis showed a positive linear association between the NLR and all-cause and cardiovascular mortality (both p > 0.05 for nonlinearity) in diabetes patients. Participants were divided into higher (> 3.48) and lower (≤ 3.48) NLR groups according to the MSRSM. In the multivariable-adjusted model, compared with participants with a lower NLR, those with a higher NLR had a significantly higher risk of both all-cause (HR 2.03, 95% confidence interval (CI) 1.64–2.51, p < 0.0001) and cardiovascular mortality (HR 2.76, 95% CI 1.84–4.14, p < 0.0001). The association was consistent in subgroup analyses based on age, sex, smoking status, drinking status, and hypertension, with no significant interaction between the aforementioned characteristics and the NLR (p interaction > 0.05). The time-dependent ROC curve showed that the areas under the curve of the 1-, 3-, 5-, and 10-year survival rates were 0.72, 0.66, 0.64, and 0.64 for all-cause mortality and 0.69, 0.71, 0.69 and 0.65, respectively, for cardiovascular mortality. CONCLUSION: An elevated NLR is independently associated with increased all-cause and cardiovascular mortality in diabetes patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-023-01998-y. |
format | Online Article Text |
id | pubmed-10541705 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105417052023-10-02 The neutrophil–lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003–2016 Dong, Gaiying Gan, Man Xu, Shilin Xie, Yanlin Zhou, Ming Wu, Liangliang Cardiovasc Diabetol Research BACKGROUND: Evidence regarding the neutrophil–lymphocyte ratio (NLR) and mortality risk in diabetes patients is scarce. This study investigated the relationship of the NLR with all-cause and cardiovascular mortality risk in diabetes patients. METHODS: Diabetes patients (n = 3251) from seven National Health and Nutrition Examination Survey (NHANES) cycles (2003–2016) were included in this study. The cause of death and mortality status of the participants were obtained from National Death Index records. Restricted cubic spline (RCS) was used to visualize the association of the NLR with mortality risk. The maximally selected rank statistics method (MSRSM) was used to determine the optimal NLR cutoff value corresponding to the most significant association with survival outcomes. Weighted multivariable Cox regression models and subgroup analyses were adopted to assess the association of the NLR with all-cause and cardiovascular mortality. Time-dependent receiver operating characteristic curve (ROC) analysis was conducted to evaluate the accuracy of the NLR in predicting survival outcomes. RESULTS: During a median follow-up of 91 months (interquartile range, 55–131 months), 896 (27.5%) of the 3251 diabetes patients died, including 261 (8.0%) with cardiovascular deaths and 635 (19.5%) with noncardiovascular deaths. The RCS regression analysis showed a positive linear association between the NLR and all-cause and cardiovascular mortality (both p > 0.05 for nonlinearity) in diabetes patients. Participants were divided into higher (> 3.48) and lower (≤ 3.48) NLR groups according to the MSRSM. In the multivariable-adjusted model, compared with participants with a lower NLR, those with a higher NLR had a significantly higher risk of both all-cause (HR 2.03, 95% confidence interval (CI) 1.64–2.51, p < 0.0001) and cardiovascular mortality (HR 2.76, 95% CI 1.84–4.14, p < 0.0001). The association was consistent in subgroup analyses based on age, sex, smoking status, drinking status, and hypertension, with no significant interaction between the aforementioned characteristics and the NLR (p interaction > 0.05). The time-dependent ROC curve showed that the areas under the curve of the 1-, 3-, 5-, and 10-year survival rates were 0.72, 0.66, 0.64, and 0.64 for all-cause mortality and 0.69, 0.71, 0.69 and 0.65, respectively, for cardiovascular mortality. CONCLUSION: An elevated NLR is independently associated with increased all-cause and cardiovascular mortality in diabetes patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-023-01998-y. BioMed Central 2023-09-29 /pmc/articles/PMC10541705/ /pubmed/37775767 http://dx.doi.org/10.1186/s12933-023-01998-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Dong, Gaiying Gan, Man Xu, Shilin Xie, Yanlin Zhou, Ming Wu, Liangliang The neutrophil–lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003–2016 |
title | The neutrophil–lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003–2016 |
title_full | The neutrophil–lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003–2016 |
title_fullStr | The neutrophil–lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003–2016 |
title_full_unstemmed | The neutrophil–lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003–2016 |
title_short | The neutrophil–lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003–2016 |
title_sort | neutrophil–lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the nhanes 2003–2016 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541705/ https://www.ncbi.nlm.nih.gov/pubmed/37775767 http://dx.doi.org/10.1186/s12933-023-01998-y |
work_keys_str_mv | AT donggaiying theneutrophillymphocyteratioasariskfactorforallcauseandcardiovascularmortalityamongindividualswithdiabetesevidencefromthenhanes20032016 AT ganman theneutrophillymphocyteratioasariskfactorforallcauseandcardiovascularmortalityamongindividualswithdiabetesevidencefromthenhanes20032016 AT xushilin theneutrophillymphocyteratioasariskfactorforallcauseandcardiovascularmortalityamongindividualswithdiabetesevidencefromthenhanes20032016 AT xieyanlin theneutrophillymphocyteratioasariskfactorforallcauseandcardiovascularmortalityamongindividualswithdiabetesevidencefromthenhanes20032016 AT zhouming theneutrophillymphocyteratioasariskfactorforallcauseandcardiovascularmortalityamongindividualswithdiabetesevidencefromthenhanes20032016 AT wuliangliang theneutrophillymphocyteratioasariskfactorforallcauseandcardiovascularmortalityamongindividualswithdiabetesevidencefromthenhanes20032016 AT donggaiying neutrophillymphocyteratioasariskfactorforallcauseandcardiovascularmortalityamongindividualswithdiabetesevidencefromthenhanes20032016 AT ganman neutrophillymphocyteratioasariskfactorforallcauseandcardiovascularmortalityamongindividualswithdiabetesevidencefromthenhanes20032016 AT xushilin neutrophillymphocyteratioasariskfactorforallcauseandcardiovascularmortalityamongindividualswithdiabetesevidencefromthenhanes20032016 AT xieyanlin neutrophillymphocyteratioasariskfactorforallcauseandcardiovascularmortalityamongindividualswithdiabetesevidencefromthenhanes20032016 AT zhouming neutrophillymphocyteratioasariskfactorforallcauseandcardiovascularmortalityamongindividualswithdiabetesevidencefromthenhanes20032016 AT wuliangliang neutrophillymphocyteratioasariskfactorforallcauseandcardiovascularmortalityamongindividualswithdiabetesevidencefromthenhanes20032016 |